Advertisement

gynäkologie + geburtshilfe

, Volume 22, Issue 1, pp 24–29 | Cite as

Integrative Medizin

Krebs und Stress — Folgen und mögliche Auswege

  • Gustav Dobos
  • Petra Voiß
  • Kyung-Eun Choi
  • Sherko Kümmel
  • Anna Paul
Fortbildung
  • 83 Downloads

Mit circa einer halben Million Neuerkrankungen gehört Krebs, insbesondere Brust-, Prostata-, Darm- und Lungenkrebs, zu den häufigsten Erkrankungen und ist trotz verbesserter Diagnose- und Behandlungsmaßnahmen die zweithäufigste Todesursache in Deutschland. Stress als begünstigender Faktor für eine Tumorprogression bei verschiedenen Krebserkrankungen ist seit Längerem bekannt. Die Rolle von Stress bei der Krebsentstehung ist hingegen noch nicht eindeutig geklärt. Mind-Body-medizinische Verfahren könnten als Anti-Stress-Interventionen den Verlauf von Krebserkrankungen positiv beeinflussen.

Literatur

  1. 1.
    Albert US et al. (2016) Diagnostik und Therapie primärer und metastasierter Mammakarzinome - Gynäkologische Probleme bei Mammakarzinompatientinnen. In: http://www.ago-online.de/fileadmin/downloads/leitlinien/mamma/Maerz2016/de/2016D%2025_Gyna%CC%88kologische%20Probleme.pdf: AGO Arbeitsgemeinschaft Gynäkologische Onkologie e.V.
  2. 2.
    Bleiker EM, Hendriks JH, Otten JD, Verbeek AL, van der Ploeg HM. Personality factors and breast cancer risk: a 13-year follow-up. Journal of the National Cancer Institute. 2008;100:213–218.CrossRefPubMedGoogle Scholar
  3. 3.
    Carlson LE et al. (2015) Mindfulness-based cancer recovery and supportive-expressive therapy maintain telomere length relative to controls in distressed breast cancer survivors. Cancer 121: 476–84.CrossRefPubMedGoogle Scholar
  4. 4.
    Carlson LE, Tamagawa R, Stephen J, Drysdale E, Zhong L, Speca M. Randomized-controlled trial of mindfulness-based cancer recovery versus supportive expressive group therapy among distressed breast cancer survivors (MINDSET): long-term follow-up results. Psychooncology. 2016 Jul;25(7):750–9. doi: 10.1002/pon.4150. Epub 2016 May 18.CrossRefPubMedGoogle Scholar
  5. 5.
    Chida Y, Steptoe A, Powell LH: Religiosity/spirituality and mortality. A systematic quantitative review. Psychother Psychosom 2009; 78: 81–90.CrossRefPubMedGoogle Scholar
  6. 6.
    Cohen L, Cole SW, Sood AK, Prinsloo S, Kirschbaum C, Arevalo JM, Jennings NB, Scott S, Vence L, Wei Q, Kentor D, Radvanyi L, Tannir N, Jonasch E, Tamboli P, Pisters L. Depressive symptoms and cortisol rhythmicity predict survival in patients with renal cell carcinoma: role of inflammatory signaling. PLoS One. 2012;7(8):e42324.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Derry et.al. (2015) Yoga and self-reported cognitive problems in breast cancer survivors: a randomized controlled trial. Psychooncology 24: 958–66. Horneber M et al. (2012) How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integrative cancer therapies 11: 187-203.CrossRefPubMedGoogle Scholar
  8. 8.
    Dobos G, et al. Integrating mindfulness in supportive cancer care: a cohort study on a mindfulness-based day care clinic for cancer survivors. Support Care Cancer. 2015.Google Scholar
  9. 9.
    Dobos G, et al. Integrative oncology for breast cancer patients: introduction of an expert-based model. BMC Cancer. 2012Google Scholar
  10. 10.
    Dobos G, Paul A. (Hg.) Mind-Body-Medizin, Elsevier München 2011.Google Scholar
  11. 11.
    Duijts SF, Zeegers MP, Borne BV. The association between stressful life events and breast cancer risk: a meta-analysis. Int J Cancer. 2003 Dec 20;107 (6):1023–9.Google Scholar
  12. 12.
    Green McDonald P, O’Connell M, Lutgendorf SK (2013). Psychoneuroimmunology and cancer: a decade of discovery, paradigm shifts, and methodological innovations. Brain Behav Immun. 2013 Mar;30 Suppl:S1-9. doi: 10.1016/j.bbi.2013.01.003. Epub 2013 Jan 16.Google Scholar
  13. 13.
    Hamer M, Chida Y, Molloy GJ. Psychological distress and cancer mortality. J Psychosom Res. 2009 Mar;66(3):255–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Hanahan, D.; Weinberg, R. A. (2011). „Hallmarks of Cancer: The Next Generation“. Cell 144(5): 646–674.CrossRefPubMedGoogle Scholar
  15. 15.
    Huang HP et al. (2015) A meta-analysis of the benefits of mindfulness-based stress reduction (MBSR) on psychological function among breast cancer (BC) survivors. Breast Cancer. 2016 Jul;23(4):568–76. doi:  10.1007/s12282-015-0604-0. Epub 2015 Mar 28}.CrossRefPubMedGoogle Scholar
  16. 16.
    Johns SA et al. (2015) Randomized controlled pilot study of mindfulness-based stress reduction for persistently fatigued cancer survivors. Psychooncology. 24(8):885–93. doi:10.1002/pon.3648. Epub 2014 Aug 17.CrossRefPubMedGoogle Scholar
  17. 17.
    Kroenke CH, Kubzansky LD, Schernhammer ES, Holmes MD, Kawachi I. Social networks, social support, and survival after breast cancer diagnosis. J Clin Obncol. 1;24(7):1105-11.Google Scholar
  18. 18.
    Kümmel S, Schmidt M. (2016) Diagnostik und Therapie primärer und metastasierter Mammakarzinome - Komplementäre Therapie „Survivorship“. In: http://www.ago-online.de/fileadmin/downloads/leitlinien/mamma/Maerz2016/de/2016D%2024_Komplementaere%20Therapie.pdf: AGO Arbeitsgemeinschaft Gynäkologische Onkologie e.V.
  19. 19.
    Kwok A et al. (2015) Dietary experiences and support needs of women who gain weight following chemotherapy for breast cancer. Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer 23: 1561–1568.CrossRefGoogle Scholar
  20. 20.
    Lillberg K, Verkasalo PK, Kaprio J, Teppo L, Helenius H, Koskenvuo M. Stressful life events and risk of breast cancer in 10,808 women: a cohort study. Am J Epidemiol. 2003 Mar 1;157(5):415–23.CrossRefPubMedGoogle Scholar
  21. 21.
    Lutgendorf SK, De Geest K, Bender D, Ahmed A, Goodheart MJ, Dahmoush L, Zimmerman MB, Penedo FJ, Lucci JA 3rd, Ganjei-Azar P, Thaker PH, Mendez L, Lubaroff DM, Slavich GM, Cole SW, Sood AK. Social influences on clinical outcomes of patients with ovarian cancer. J Clin Oncol. 2012 Aug 10;30(23):2885–90.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Mills PJ, Schneider RH, Hill D, Walton KG, Wallace RK. Beta-adrenergic receptor sensitivity in subjects practicing transcendental meditation. J Psychosom Res. 1990;34(1):29–33.CrossRefPubMedGoogle Scholar
  23. 23.
    Morgan N, Irwin MR, Chung M, Wang C. (2014). The effects of mind-body therapies on the immune system: meta-analysis. PLoS One. 2014 Jul 2;9(7):e100903. doi:  10.1371/journal.pone.0100903. eCollection 2014.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Ornish D et al. (2005). Intensive lifestyle changes may affect the progression of prostate cancer. J Urol. 2005 Sep;174(3):1065–9; discussion 1069-70.CrossRefPubMedGoogle Scholar
  25. 25.
    Palesh O et al. (2014) Actigraphy-measured sleep disruption as a predictor of survival among women with advanced breast cancer. Sleep. 1;37(5):837–42. doi:  10.5665/sleep.3642.PubMedPubMedCentralGoogle Scholar
  26. 26.
    Palesh O et al. (2016) RCT utilizing acupuncture for management of insomnia associated with cancer. Journal of Clinical Oncology, 2015 ASCO Annual Meeting 33, No 15_suppl.Google Scholar
  27. 27.
    Palesh O, Butler LD, Koopman C, Giese-Davis J, Carlson R, Spiegel D. Stress history and breast cancer recurrence. J Psychosom Res. 2007 Sep;63(3):233–9.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Petticrew M. Cancer-stress link: the truth. Nurs Times. 1999 Mar 3-9;95(9):52–3.PubMedGoogle Scholar
  29. 29.
    Pinquart M, Duberstein PR. Associations of social networks with cancer mortality: a meta-analysis. Crit Rev Oncol Hematol. 2010 Aug;75(2):122–37.CrossRefPubMedGoogle Scholar
  30. 30.
    Reynolds P, Kaplan GA. Social connections and risk for cancer: prospective evidence from the Alameda County Study. Behav Med. 1990 Fall;16(3):101–10.CrossRefPubMedGoogle Scholar
  31. 31.
    Robert-Koch-Institut. Krebs in Deutschland 2011/2012. 10. Ausgabe, 2015. Zentrum für Krebsregisterdaten, GEKID. Gesundheitsberichterstattung des Bundes. Robert Koch-Institut (Hrsg) und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (Hrsg). Berlin.Google Scholar
  32. 32.
    Satin JR, et al.: Depression as a predictor of disease progression and moritality in cancer patients: a meta-analysis. Cancer 2009; 115: 5349–5361.CrossRefPubMedGoogle Scholar
  33. 33.
    Sprehn GC, Chambers JE, Saykin AJ, Konski A, Johnstone PA. Decreased cancer survival in individuals separated at time of diagnosis: critical period for cancer pathophysiology? Cancer. 2009 Nov 1;115(21):5108–16.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Sprod LK (2015) Effects of yoga on cancer-related fatigue and global side-effect burden in older cancer survivors. Journal of Geriatric Oncology 6: 8–14.CrossRefPubMedGoogle Scholar
  35. 35.
    Steele et al., 2007. Stressful life events and risk of breast cancer in 10,808 women: a cohort study. Am J Epidemiol. 2003 Mar 1;157(5):415–23.Google Scholar
  36. 36.
    Thaker PH et al. (2006) Chronic Stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinomaNature Medicine 12, 939 - 944 (2006) Published online: 23 July 2006 doi: 10.1038/nm1447
  37. 37.
    Watkins JL et al., (2015) Clinical Impact of selective and non-selective beta blockers on survival in ovarian cancer patients. Cancer October 1; 121(19): 3444–3451. doi: 10.1002/cncr.29392.Google Scholar
  38. 38.
    Zeng Y et al. (2014) Health benefits of qigong or tai chi for cancer patients: a systematic review and meta-analyses. Complementary therapies in medicine 22: 173–186.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Medizin 2017

Authors and Affiliations

  • Gustav Dobos
    • 1
  • Petra Voiß
    • 2
  • Kyung-Eun Choi
    • 2
  • Sherko Kümmel
    • 2
  • Anna Paul
    • 2
  1. 1.Universität Duisburg-Essen, Lehrstuhl für Naturheilkunde und Integrative Medizin, Kliniken Essen-Mitte, KnappschaftskrankenhausEssenDeutschland
  2. 2.

Personalised recommendations